GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity
- Conditions
- Dentine Hypersensitivity
- Interventions
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 113
- Registration Number
- NCT01592851
- Locations
- πΊπΈ
BioSci Research America, Inc., Las Vegas, Nevada, United States
The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity
- Conditions
- Dentine Hypersensitivity
- Interventions
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2014-03-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 120
- Registration Number
- NCT01592864
- Locations
- πΊπΈ
BioSci Research America, Inc., Las Vegas, Nevada, United States
Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium
- Conditions
- Infections, Rotavirus
- Interventions
- Other: Data collection
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1
- Registration Number
- NCT01592838
A Study to Compare Two Paracetamol Formulations.
- Conditions
- Pain
- Interventions
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2014-11-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 30
- Registration Number
- NCT01592227
- Locations
- πΊπΈ
MDS Pharma Services ARIZONA, Phoenix, Arizona, United States
Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain
- Conditions
- Influenza
- Interventions
- Procedure: Throat swab and/or nasopharyngeal swabOther: Data collection
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2018-07-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 501
- Registration Number
- NCT01592799
- Locations
- πͺπΈ
GSK Investigational Site, Bilbao, Spain
WEUKBRE5559: IMI PROTECT: Benzodiazepines & Fracture
- Conditions
- Anxiety Disorders
- Interventions
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1
- Registration Number
- NCT01587833
IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer
- Conditions
- Hypertension
- Interventions
- Drug: CCB use
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1
- Registration Number
- NCT01587742
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 196
- Registration Number
- NCT01587703
- Locations
- π¬π§
GSK Investigational Site, Newcastle upon Tyne, United Kingdom
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 80
- Registration Number
- NCT01587924
- Locations
- πΈπͺ
GSK Investigational Site, Uppsala, Sweden
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.
- Conditions
- Cough
- Interventions
- Drug: GSK2339345 (Inhaled) Single DoseDrug: GSK2339345 (Inhaled) Repeat DoseOther: Placebo (Inhaled) Single DoseOther: Placebo (Inhaled) Repeat Dose
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT01587716
- Locations
- π¬π§
GSK Investigational Site, London, United Kingdom